Skip to main content

Table 6 Comorbidity and symptoms depending on smoking habits

From: Microscopic colitis found together with celiac disease in a female population is associated with one episode of lymphocytic colitis

 

Never smoking

N = 41

Past smoking

N = 64

Present smoking

N = 53

P-value

Comorbidity

 Hypertension

Missing value

11 (26.8)

5

26 (40.6)

7

17 (32.1)

4

0.541

 Rheumatoid arthritis

Missing value

9 (22.0)

5

13 (20.3)

12

11 (20.8)

5

0.760

 Asthma and/or bronchitis

Missing value

6 (14.6)

6

9 (14.1)

13

10 (18.9)

4

0.492

 Diabetes

Missing value

5 (12.2)

5

4 (6.3)

14

2 (3.8)

5

0.299

 Celiac disease

Missing value

3 (7.3)

6

8 (12.5)

15

0

9

0.009

 Gastric ulcer

Missing value

7 (17.1)

1

7 (10.9)

11

9 (17.0)

4

0.607

 Thyroid disease

Missing value

6 (14.6)

5

14 (21.9)

11

8 (15.1)

9

0.529

 Cancer

Missing value

2 (4.9)

6

4 (6.3)

14

7 (13.2)

6

0.396

Drug treatment

 Corticosteroids

11 (26.8)

19 (29.7)

18 (34.0)

0.759

 Proton pump inhibitors

14 (34.1)

15 (23.4)

12 (22.6)

0.392

 Selective serotonin reuptake inhibitors

9 (22.0)

9 (14.1)

12 (22.6)

0.410

 Statins

6 (14.6)

15 (23.4)

7 (13.2)

0.349

 Thyroid hormones

6 (14.6)

13 (20.3)

7 (13.2)

0.533

Gastrointestinal symptoms

 Abdominal pain

5 (1–15)

31 (13–50)

31 (6–54)

41 (17–59)

0.154

 Diarrhea

3 (0–10)

46 (16–62)

40 (14–73)

54 (28–80)

0.133

 Constipation

9 (1–22)

8 (2–20)

8 (2–25)

8 (3–22)

0.871

 Bloating and flatulence

14 (1–29)

49 (18–60)

47 (22–75)

63 (28–80)

0.044

 Vomiting and nausea

2 (0–3)

5 (0–19)

5 (2–23)

14 (3–47)

0.065

 Intestinal influence on daily life

2 (0–18)

36 (16–72)

36 (12–71)

64 (28–89)

0.012

 Psychological well-being

4 (0–16)

22 (6–34)

22 (10–48)

40 (12–67)

0.025

  1. Comorbidity reflects whether the patients ever have been treated for any of these diseases. Missing values mean that the participant has not answered the question whether they have had the disease or not in the questionnaire. Gastrointestinal symptoms were assessed by the Visual Analog Scale for Irritable Bowel Syndrome, 0–100 mm, where 0 represents no symptoms and 100 maximal symptoms [20]. Reference values for VAS-IBS from healthy women are shown within brackets [21]. Values are given as number and percentages or median and interquartile ranges. Kruskal–Wallis test or Fisher´s exact test. P ≤ 0.05 was considered statistically significant